News

January 10, 2020January 10, 2020

Dust Exposure, PTSD Linked to 9/11 Attacks May Raise Risk of Lupus, Other Autoimmune Diseases, Study Finds

News

Exposure to dust and having post-traumatic stress disorder (PTSD) as a result of the 9/11 terrorist attacks in New York are associated with an increased risk of developing autoimmune ... Read more

January 8, 2020January 8, 2020

Use of Glucocorticoids Linked to Organ Damage in SLE, Study Finds

News

Using glucocorticoids to treat inflammation in systemic lupus erythematosus (SLE) was associated with organ damage in patients without active disease, a large study found. These findings draw attention to ... Read more

January 6, 2020January 6, 2020

President Trump Signs Bills Bringing $19M to Lupus Research and Education

News

Culminating more than a year of advocacy by the Lupus Foundation of America and others, President Donald Trump has signed into law provisions for nearly $19 million in new ... Read more

January 3, 2020January 3, 2020

Benlysta Add-on Therapy Improves Kidney Function in People with Lupus Nephritis, Phase 3 Trial Shows

News

Adding Benlysta (belimumab) to standard therapy increased the percentage of people with active lupus nephritis who experienced improved renal function in a Phase 3 trial. The BLISS-LN study (NCT01639339) ... Read more

December 20, 2019December 20, 2019

Childhood Abuse May Increase Risk of Developing SLE in Adulthood, Study Finds

News

Physical and emotional abuse during childhood may increase the risk of developing systemic lupus erythematosus (SLE) later in life, a new study has found. The study, “Association of Childhood ... Read more

December 18, 2019December 18, 2019

Itolizumab Granted FDA Fast Track Designation as Potential Treatment for Lupus Nephritis

News

The U.S. Food and Drug Administration (FDA) has granted fast track designation to itolizumab as a potential therapy for lupus nephritis, a common and serious complication of systemic lupus erythematosus (SLE) that can lead to kidney ... Read more

December 13, 2019December 13, 2019

Study Supports Patient-reported Tool Measuring Fatigue’s Impact on Daily Activities

News

Fatigue has a major impact on quality of life in people with systemic lupus erythematosus, and measuring it using a patient-reported tool may prove useful in clinical trials, new ... Read more

December 11, 2019December 11, 2019

Lupus Research Alliance Gala Raises $3M to Support Disease Research

News

This year’s Lupus Research Alliance (LRA) Breaking Through Gala, billed as the world’s largest single lupus fundraising event, took in $3 million for research into the autoimmune disorder. Some 600 ... Read more

December 9, 2019December 9, 2019

Biogen’s BIIB059 Eases Disease Activity in SLE, Lupus Affecting Skin, Top-line Results Show

News

Treatment with an investigational antibody therapy known as BIIB059 was well-tolerated and decreased disease activity in people with cutaneous lupus erythematosus (CLE) — lupus affecting the skin — with ... Read more

December 6, 2019December 6, 2019

Voclosporin Plus Standard Care Safely Helps Kidneys in Lupus Nephritis, Phase 3 Trial Shows

News

Adding the experimental oral therapy voclosporin to standard-of-care treatment is safe and nearly doubles the proportion of complete kidney responses in people with lupus nephritis, according to top-line data ... Read more

This is a short description about myself and what this site is about. I hope you enjoy being here!

News

Dust Exposure, PTSD Linked to 9/11 Attacks May Raise Risk of Lupus, Other Autoimmune Diseases, Study Finds

Use of Glucocorticoids Linked to Organ Damage in SLE, Study Finds

President Trump Signs Bills Bringing $19M to Lupus Research and Education

Benlysta Add-on Therapy Improves Kidney Function in People with Lupus Nephritis, Phase 3 Trial Shows

Childhood Abuse May Increase Risk of Developing SLE in Adulthood, Study Finds

Itolizumab Granted FDA Fast Track Designation as Potential Treatment for Lupus Nephritis

Study Supports Patient-reported Tool Measuring Fatigue’s Impact on Daily Activities

Lupus Research Alliance Gala Raises $3M to Support Disease Research

Biogen’s BIIB059 Eases Disease Activity in SLE, Lupus Affecting Skin, Top-line Results Show

Voclosporin Plus Standard Care Safely Helps Kidneys in Lupus Nephritis, Phase 3 Trial Shows

Pin It on Pinterest